Randomized phase II trial of daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer

Autor: Suzuki, Aya, Maemondo, Makoto, Sugawara, Shunichi, Nakagawa, Taku, Taima, Kageaki, Inoue, Akira, Matsuno, Kazuhiko, Usui, Kazuhiro, Yokoi, Takashi, Kanbe, Mariko, Nukiwa, Toshihiro
Zdroj: In Cancer Treatment and Research Communications 2017 12:56-61
Databáze: ScienceDirect